Revenue rebounded 6.5% YoY in 2027Q1 to $265.7M, but gross margin compressed to 51.3% from 59.2% in 2025Q4, while operating margin fell to 19.8% from 29.8%, driven by a 19% SG&A increase.
Prestige Consumer Healthcare Inc. (PBH) annual income statement — 26-year revenue, gross profit & net income history
| Metric | TTM | Mar'26 | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Mar'09 | Mar'08 | Mar'07 | Mar'06 | Mar'05 | Mar'04 | Mar'03 | Mar'02 | Mar'01 |
|---|
| Sales/Revenue | 1.17B | 1.09B | 1.14B | 1.13B | 1.13B | 1.09B | 943.37M | 963.01M | 975.78M | 1.04B | 882.06M | 806.25M | 714.62M | 601.88M | 623.6M | 441.08M | 336.51M | 302.02M | 312.71M | 326.6M | 318.63M | 296.67M | 303.32M | 87.92M | 71.73M | 46.25M | 8.65M |
| Revenue Growth % | 5.07% | -4.31% | 1.1% | -0.21% | 3.76% | 15.21% | -2.04% | -1.31% | -6.28% | 18.04% | 9.4% | 12.82% | 18.73% | -3.48% | 41.38% | 31.08% | 11.42% | -3.42% | -4.25% | 2.5% | 7.4% | -2.19% | 244.99% | 22.56% | 55.09% | 434.41% | - |
| Cost of Goods Sold | 560.12M | 514.07M | 503.3M | 500.91M | 502.43M | 466.17M | 395.89M | 410.79M | 420.2M | 464.67M | 381.77M | 339.04M | 308.4M | 261.83M | 276.38M | 213.7M | 165.63M | 144.59M | 149.44M | 158.1M | 153.15M | 139.43M | 141.35M | 36.28M | 27.02M | 18.73M | 3.08M |
| COGS % of Revenue | - | 47.22% | 44.24% | 44.51% | 44.55% | 42.89% | 41.97% | 42.66% | 43.06% | 44.63% | 43.28% | 42.05% | 43.16% | 43.5% | 44.32% | 48.45% | 49.22% | 47.87% | 47.79% | 48.41% | 48.06% | 47% | 46.6% | 41.26% | 37.66% | 40.51% | 35.53% |
| Gross Profit | 606.96M | 574.64M | 634.46M | 624.45M | 625.29M | 620.65M | 547.47M | 552.22M | 555.58M | 576.5M | 500.29M | 467.21M | 406.22M | 340.05M | 347.22M | 227.38M | 170.88M | 157.44M | 163.27M | 168.51M | 165.49M | 157.24M | 161.97M | 51.64M | 44.72M | 27.52M | 5.58M |
| Gross Margin % | 52.01% | 52.78% | 55.76% | 55.49% | 55.45% | 57.11% | 58.03% | 57.34% | 56.94% | 55.37% | 56.72% | 57.95% | 56.84% | 56.5% | 55.68% | 51.55% | 50.78% | 52.13% | 52.21% | 51.59% | 51.94% | 53% | 53.4% | 58.74% | 62.34% | 59.49% | 64.47% |
| Gross Profit Growth % | - | -9.43% | 1.6% | -0.14% | 0.75% | 13.37% | -0.86% | -0.6% | -3.63% | 15.24% | 7.08% | 15.01% | 19.46% | -2.06% | 52.7% | 33.07% | 8.54% | -3.57% | -3.11% | 1.82% | 5.25% | -2.92% | 213.63% | 15.49% | 62.5% | 393.15% | - |
| Operating Expenses | 315.74M | 265.23M | 297.69M | 282.02M | 647.71M | 290.73M | 250.07M | 261.07M | 259.9M | 360.64M | 242.85M | 206.9M | 198.66M | 151.44M | 155.33M | 124.56M | 94.73M | 75.98M | 81.21M | 77.09M | 70.81M | 73.33M | 68.4M | 34.84M | 17.35M | 12.57M | 709K |
| OpEx % of Revenue | - | 24.36% | 26.16% | 25.06% | 57.44% | 26.75% | 26.51% | 27.11% | 26.63% | 34.64% | 27.53% | 25.66% | 27.8% | 25.16% | 24.91% | 28.24% | 28.15% | 25.16% | 25.97% | 23.6% | 22.22% | 24.72% | 22.55% | 39.63% | 24.19% | 27.17% | 8.19% |
| Selling, General & Admin | 296.19M | 265.23M | 263.93M | 259.47M | 252.41M | 264.8M | 223.69M | 236.31M | 232.85M | 332.21M | 217.5M | 183.22M | 180.92M | 137.95M | 142.1M | 113.83M | 84.86M | 65.43M | 69.99M | 66.08M | 60.42M | 53.24M | 58.6M | 11.09M | 12.07M | 8.58M | 709K |
| SG&A % of Revenue | - | 24.36% | 23.2% | 23.06% | 22.38% | 24.37% | 23.71% | 24.54% | 23.86% | 31.91% | 24.66% | 22.73% | 25.32% | 22.92% | 22.79% | 25.81% | 25.22% | 21.66% | 22.38% | 20.23% | 18.96% | 17.95% | 19.32% | 12.61% | 16.83% | 18.54% | 8.19% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 3M | 0 | 33.76M | 22.55M | 395.29M | 25.93M | 26.38M | 24.76M | -476K | 28.43M | 25.35M | 23.68M | 17.74M | 13.49M | 13.23M | 10.73M | 9.88M | 10.55M | 11.22M | 11.01M | 10.38M | 20.09M | 9.8M | 23.75M | 5.27M | 3.99M | 0 |
| Operating Income | 291.21M | 309.41M | 336.77M | 342.43M | -22.41M | 329.92M | 297.4M | 291.15M | 67.5M | 215.87M | 205.61M | 260.31M | 207.56M | 188.62M | 191.88M | 102.82M | 76.14M | 78.7M | -167.53M | 91.41M | 94.68M | 83.9M | 93.57M | 16.8M | 27.37M | 14.95M | 4.87M |
| Operating Margin % | 24.95% | 28.42% | 29.6% | 30.43% | -1.99% | 30.36% | 31.53% | 30.23% | 6.92% | 20.73% | 23.31% | 32.29% | 29.04% | 31.34% | 30.77% | 23.31% | 22.63% | 26.06% | -53.57% | 27.99% | 29.72% | 28.28% | 30.85% | 19.11% | 38.15% | 32.32% | 56.28% |
| Operating Income Growth % | - | -8.13% | -1.65% | 1627.68% | -106.79% | 10.93% | 2.15% | 331.32% | -68.73% | 4.99% | -21.01% | 25.42% | 10.04% | -1.7% | 86.62% | 35.04% | -3.25% | 146.98% | -283.26% | -3.45% | 12.85% | -10.33% | 456.86% | -38.6% | 83.06% | 206.92% | - |
| EBITDA | 327.88M | 340.68M | 366.95M | 373.1M | 10.21M | 362.01M | 327.57M | 320.15M | 99.28M | 249.29M | 231.41M | 283.99M | 225.3M | 202.1M | 205.12M | 113.56M | 86.25M | 92.08M | -156.31M | 105.44M | 108.32M | 97.33M | 106.31M | 22.23M | 32.64M | 18.94M | 4.87M |
| EBITDA Margin % | 28.09% | 31.29% | 32.25% | 33.15% | 0.91% | 33.31% | 34.72% | 33.24% | 10.17% | 23.94% | 26.23% | 35.22% | 31.53% | 33.58% | 32.89% | 25.74% | 25.63% | 30.49% | -49.98% | 32.28% | 34% | 32.81% | 35.05% | 25.29% | 45.5% | 40.95% | 56.28% |
| EBITDA Growth % | -9.24% | -7.16% | -1.65% | 3554.3% | -97.18% | 10.52% | 2.32% | 222.47% | -60.17% | 7.73% | -18.52% | 26.05% | 11.48% | -1.47% | 80.63% | 31.66% | -6.33% | 158.91% | -248.25% | -2.67% | 11.29% | -8.45% | 378.2% | -31.89% | 72.33% | 288.87% | - |
| D&A (Non-Cash Add-back) | 36.66M | 31.27M | 30.17M | 30.68M | 32.63M | 32.09M | 30.16M | 29M | 31.78M | 33.43M | 25.79M | 23.68M | 17.74M | 13.49M | 13.23M | 10.73M | 10.11M | 13.38M | 11.22M | 14.02M | 13.64M | 13.43M | 12.74M | 5.43M | 5.27M | 3.99M | 0 |
| EBIT | 278.65M | 299.83M | 331.82M | 343.19M | -24.75M | 326.75M | 286.44M | 287.72M | 67.03M | 322.3M | 204.4M | 242.51M | 208.78M | 170.39M | 190.45M | 102.5M | 75.85M | 75.67M | -169.28M | 92.28M | 95.65M | 83.9M | 63.87M | 16.8M | 27.37M | 14.95M | 4.87M |
| Net Interest Income | -66.07M | -42.34M | -47.63M | -67.16M | -69.16M | -64.29M | -82.33M | -96.22M | -105.08M | -105.88M | -93.34M | -85.16M | -81.23M | -68.58M | -84.41M | -41.32M | -27.32M | -22.93M | -28.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 342K | 217K | 388K | 203K | 162K | 92K | 60K | 13K | 18K | 0 | 1K | 143K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 66.07M | 42.34M | 47.63M | 67.16M | 69.16M | 64.29M | 82.33M | 96.57M | 105.3M | 106.27M | 93.55M | 85.32M | 81.33M | 68.64M | 84.42M | 41.34M | 27.32M | 22.94M | 28.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -78.64M | -51.91M | -52.59M | -66.4M | -71.5M | -67.46M | -93.29M | -100M | -105.56M | -108.39M | -94.79M | -103.13M | -80.1M | -86.87M | -85.85M | -41.67M | -27.62M | -25.59M | -28.44M | -37.21M | -39.51M | -36.35M | -71.59M | -9.88M | -21.55M | -13.97M | -2.48M |
| Pretax Income | 212.58M | 257.5M | 284.19M | 276.02M | -93.92M | 262.46M | 204.11M | 191.15M | -38.05M | 107.09M | 110.85M | 157.19M | 127.46M | 101.75M | 106.03M | 61.16M | 48.53M | 53.11M | -195.96M | 54.21M | 55.18M | 47.56M | 21.98M | 6.92M | 5.82M | 979K | 2.39M |
| Pretax Margin % | 18.21% | 23.65% | 24.98% | 24.53% | -8.33% | 24.15% | 21.64% | 19.85% | -3.9% | 10.29% | 12.57% | 19.5% | 17.84% | 16.91% | 17% | 13.87% | 14.42% | 17.59% | -62.66% | 16.6% | 17.32% | 16.03% | 7.25% | 7.87% | 8.11% | 2.12% | 27.63% |
| Income Tax | 57.48M | 67.19M | 69.58M | 66.69M | -11.61M | 57.08M | 39.43M | 48.87M | -2.25M | -232.48M | 41.45M | 57.28M | 49.2M | 29.13M | 40.53M | 23.95M | 19.35M | 21.85M | -9.19M | 20.29M | 19.1M | 21.28M | 8.52M | 2.74M | 20.72M | 434K | -137K |
| Effective Tax Rate % | 27.04% | 26.1% | 24.49% | 24.16% | 12.36% | 21.75% | 19.32% | 25.57% | 5.93% | -217.1% | 37.4% | 36.44% | 38.6% | 28.63% | 38.22% | 39.15% | 39.87% | 41.14% | 4.69% | 37.43% | 34.61% | 44.75% | 38.77% | 39.56% | 355.95% | 44.33% | -5.73% |
| Net Income | 155.1M | 190.3M | 214.6M | 209.34M | -82.31M | 205.38M | 164.68M | 142.28M | -35.8M | 339.57M | 69.39M | 99.91M | 78.26M | 72.61M | 65.5M | 37.21M | 29.22M | 32.12M | -186.78M | 33.92M | 36.08M | 26.28M | 13.46M | 4.18M | -14.9M | 545K | 2.53M |
| Net Margin % | 13.29% | 17.48% | 18.86% | 18.6% | -7.3% | 18.9% | 17.46% | 14.77% | -3.67% | 32.61% | 7.87% | 12.39% | 10.95% | 12.06% | 10.5% | 8.44% | 8.68% | 10.63% | -59.73% | 10.39% | 11.32% | 8.86% | 4.44% | 4.76% | -20.77% | 1.18% | 29.21% |
| Net Income Growth % | -22.78% | -11.33% | 2.52% | 354.34% | -140.07% | 24.71% | 15.74% | 497.43% | -110.54% | 389.33% | -30.54% | 27.66% | 7.77% | 10.85% | 76.03% | 27.35% | -9.01% | 117.19% | -650.65% | -5.98% | 37.3% | 95.24% | 221.75% | 128.08% | -2833.21% | -78.44% | - |
| Net Income (Continuing) | 155.1M | 190.3M | 214.6M | 209.34M | -82.31M | 205.38M | 164.68M | 142.28M | -35.8M | 339.57M | 69.39M | 99.91M | 78.26M | 72.61M | 65.5M | 37.21M | 29.18M | 31.26M | -186.78M | 33.92M | 36.08M | 26.28M | 10.22M | 4.18M | 2.53M | 611K | 2.47M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 3.26 | 3.91 | 4.29 | 4.17 | -1.65 | 4.04 | 3.25 | 2.78 | -0.69 | 6.34 | 1.30 | 1.88 | 1.49 | 1.39 | 1.27 | 0.73 | 0.58 | 0.64 | -3.74 | 0.68 | 0.72 | 0.53 | -0.55 | 0.02 | -0.30 | -0.55 | 0.10 |
| EPS Growth % | -19.6% | -8.86% | 2.88% | 352.73% | -140.84% | 24.31% | 16.91% | 502.9% | -110.88% | 387.69% | -30.85% | 26.17% | 7.19% | 9.45% | 73.97% | 25.86% | -9.38% | 117.11% | -650% | -5.56% | 35.85% | 196.36% | -2850% | 106.67% | 45.45% | -677.73% | - |
| EPS (Basic) | - | 3.93 | 4.32 | 4.21 | -1.65 | 4.09 | 3.28 | 2.81 | -0.69 | 6.34 | 1.31 | 1.89 | 1.50 | 1.41 | 1.29 | 0.74 | 0.58 | 0.64 | -3.74 | 0.68 | 0.73 | 0.54 | -0.55 | 0.02 | -0.30 | -0.55 | 0.10 |
| Diluted Shares Outstanding | 47.59M | 48.72M | 50.08M | 50.18M | 49.89M | 50.84M | 50.6M | 51.14M | 52.07M | 53.53M | 53.36M | 53.14M | 52.67M | 52.35M | 51.44M | 50.75M | 50.34M | 50.09M | 49.94M | 50.04M | 50.02M | 50.01M | 27.55M | 26.57M | 50.01M | 27.55M | 26.54M |
| Basic Shares Outstanding | 47.49M | 48.46M | 49.7M | 49.76M | 49.88M | 50.26M | 50.21M | 50.72M | 51.88M | 53.1M | 52.98M | 52.75M | 52.17M | 51.64M | 50.63M | 50.27M | 50.08M | 50.01M | 49.94M | 49.75M | 49.46M | 48.91M | 27.55M | 26.57M | 48.91M | 27.55M | 24.62M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying PBH stock.
For fiscal year 2026, Prestige Consumer Healthcare Inc. (PBH) reported total revenue of $1.09B. This represents a 12478.9% increase compared to $8.7M in 2001.
Prestige Consumer Healthcare Inc. (PBH) is profitable, generating $190.3M in net income for the fiscal year ending 2026 with a net profit margin of 17.5%.
Prestige Consumer Healthcare Inc. (PBH) reported an operating income of $309.4M, resulting in an operating profit margin of 28.4%. This margin reflects the operational efficiency of the business before interest and taxes.
Prestige Consumer Healthcare Inc. (PBH) generated $574.6M in gross profit for the year, representing a gross profit margin of 52.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Persistent top-line contraction
Metrics are mathematically derived from official filings.
Top-Line Contraction Persists
PBH's revenue declined 4.3% year-over-year in 2026Q1, marking the fifth consecutive quarter of negative growth, though 2027Q1 showed a 6.5% rebound, suggesting a potential inflection.
The revenue trend has been consistently negative through fiscal 2026, with declines ranging from -2.4% to -6.6% year-over-year. The most recent quarter (2027Q1) shows a return to positive growth at 6.5%, which may indicate a stabilization or a one-off boost. Given the company's reliance on M&A for growth, organic performance appears challenged, and investors should monitor whether this rebound is sustainable or a temporary recovery.
Gross Margin Resilience Amid Volume Pressure
Gross margin averaged 54.5% over the last ten quarters, with 2027Q1 at 51.3%, down from 59.2% in 2025Q4, indicating potential cost pressures or mix shifts.
Despite revenue declines, gross margins have remained relatively stable, hovering around 54-56% for most of the period. The dip to 51.3% in 2027Q1 is notable and may reflect higher input costs or promotional activity. Compared to peers like CHD (44.7%) and PRGO (35.1%), PBH's gross margin is strong, underscoring its brand pricing power. However, the recent compression warrants monitoring for structural changes in cost structure.
Operating Leverage Fading
Operating margin fell from 29.8% in 2025Q4 to 19.8% in 2027Q1, as SG&A rose 19% year-over-year while revenue grew only 6.5%, indicating negative operating leverage.
The operating margin contraction in 2027Q1 is significant, driven by a sharp increase in SG&A expenses to $78.0M from $63.4M in the prior year quarter. This suggests that the company is investing more in selling and marketing to support growth, but the revenue increase did not fully offset the expense growth. Historically, operating margins have been in the high-20s to low-30s, so the current level is below trend. If SG&A remains elevated, margin recovery may be limited.
EPS Volatility Masks Underlying Stability
Diluted EPS swung from $1.22 in 2025Q3 to $0.61 in 2027Q1, with net income impacted by non-operating items and tax effects, as SBC averaged $2.8M per quarter.
Net income and EPS have been volatile, with 2027Q1 EPS down 35.8% year-over-year despite revenue growth. This suggests that non-operating items, such as interest expense or tax adjustments, are influencing results. Stock-based compensation is modest, averaging around $2.8M per quarter, which is not a major drag. Investors should focus on operating income as a cleaner measure of performance, which has been more stable, though it also declined in 2027Q1.
SG&A Spike Drives Margin Compression
SG&A expenses rose to $78.0M in 2027Q1, up 19% year-over-year, while COGS increased only 13%, indicating that overhead is the primary driver of margin pressure.
The cost structure is dominated by COGS and SG&A, with no R&D. In 2027Q1, SG&A as a percentage of revenue jumped to 29.4% from 25.4% in the prior year quarter, a significant increase. This could be due to higher advertising and promotion spending to combat competitive pressures or support new product launches. If this elevated spending is temporary, margins may recover; otherwise, it signals a structural shift in the cost base.
2025Q4 Peak Marks Turning Point
2025Q4 represented the peak in gross margin (59.2%) and operating margin (29.8%) over the last ten quarters, followed by a downward trend in subsequent periods.
The fiscal 2025 fourth quarter appears to be the high-water mark for profitability, with gross margin at 59.2% and operating margin at 29.8%. Since then, margins have declined, with 2027Q1 gross margin at 51.3% and operating margin at 19.8%. This inflection suggests that the company is facing increased cost pressures or competitive dynamics that are eroding its historical profitability. The sustainability of the business model depends on whether this is a temporary setback or a new normal.
What Could Invalidate the Base Case
The recent EPS miss and persistent revenue decline suggest that the market's optimism may be misplaced, as cost discipline may not offset top-line weakness.
Short-sellers could argue that the -4.3% revenue decline is not a temporary blip but a structural erosion of brand equity, as private-label competition intensifies. The 2027Q1 gross margin drop to 51.3% from 59.2% in 2025Q4 may indicate that pricing power is waning, and the elevated SG&A could be a defensive spend that fails to revive growth. If the company cannot return to organic growth, the reliance on M&A becomes a treadmill, and the current valuation may not adequately discount the risk of continued contraction.